Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Adenosine Triphosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 9/20 | 0.76 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.76 |
| ▸ | P2RY11 | Q96G91 | 3/20 | 0.76 |
| ▸ | SRC | P12931 | 2/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.76 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.76 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.76 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.76 |
| ▸ | LDHA | P00338 | 1/20 | 0.76 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.76 |
| ▸ | FBP1 | P09467 | 1/20 | 0.76 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.76 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.76 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.76 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.76 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.76 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.76 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.76 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.76 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Triphosphate SCHEMBL3332142 | 1.00 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL27531093 | 0.99 | P2RY1 (0.75) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL30522306 | 0.99 | P2RY1 (0.78) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL29352529 | 0.99 | P2RY1 (0.78) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL28359 | 0.99 | P2RY1 (0.78) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL3040417 | 0.99 | P2RY1 (0.78) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL27783353 | 0.98 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL4594623 | 0.98 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL3498805 | 0.98 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 | |
| Adenosine Triphosphate SCHEMBL29760430 | 0.98 | P2RY1 (0.76) | P2RY1P2RY2P2RY11SRCSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3474836-B1 | SALBUTAMOL-CONTAINING OPHTHALMIC MEDICAMENT | REKIK RAOUF (TN) | 2024-01-17 | — | — | EP | disclosed |